CTNM (Contineum Therapeutics, Inc. Class A Common Stock) Stock Analysis - Insider Trades
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) is a publicly traded Healthcare sector company. As of May 21, 2026, CTNM trades at $13.40 with a market cap of $480.79M and a P/E ratio of -6.13. CTNM moved +5.72% today. Year to date, CTNM is +33.90%; over the trailing twelve months it is +249.61%. Its 52-week range spans $3.35 to $20.24. Analyst consensus is strong buy with an average price target of $21.00. Rallies surfaces CTNM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading CTNM stock inside the company?
Recent CTNM insider activity includes Lorrain Daniel S. sold 3.87K, Lorrain Daniel S. sold 300, Lorrain Daniel S. sold 4.17K, Lorrain Daniel S. sold 4.17K, and Watkins Tim sold 3.61K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
CTNM Key Metrics
Key financial metrics for CTNM
Metric
Value
Price
$13.40
Market Cap
$480.79M
P/E Ratio
-6.13
EPS
$-2.17
Dividend Yield
0.00%
52-Week High
$20.24
52-Week Low
$3.35
Volume
1
Avg Volume
0
Revenue (TTM)
$0
Net Income
$-59.98M
Gross Margin
0.00%
Recent CTNM Insider Trades
Lorrain Daniel S. sold 3.87K (~$50.54K) on May 1, 2026.
Lorrain Daniel S. sold 300 (~$4.15K) on May 1, 2026.
Lorrain Daniel S. sold 4.17K (~$56.01K) on Apr 6, 2026.
Lorrain Daniel S. sold 4.17K (~$62.59K) on Mar 2, 2026.
Recent CTNM insider activity includes Lorrain Daniel S. sold 3.87K, Lorrain Daniel S. sold 300, Lorrain Daniel S. sold 4.17K, Lorrain Daniel S. sold 4.17K, and Watkins Tim sold 3.61K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for CTNM?
Yes. Rallies tracks CTNM insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is CTNM research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CTNM. It does not provide personalized investment advice.